🇺🇸 FDA
Patent

US 11903966

Intracellular genomic transplant and methods of therapy

granted A61KA61K2239/38A61K40/11

Quick answer

US patent 11903966 (Intracellular genomic transplant and methods of therapy) held by Regents of the University of Minnesota expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32